FHS|^~\&|LABTRAK||PATH_RESULTS||200509011616||\\adlapf01\labtrak\temp\edi\out\CLAR955.HL7 BHS|^~\&|LABTRAK||PATH_RESULTS||200509011616||\\adlapf01\labtrak\temp\edi\out\CLAR955.HL7 MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143424|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|COAG^Coag Profile^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|NM|PLT^Platelets^L||302|10^9/L|150-450|N OBX|2|NM|PT^Prothrombin Time (PT)^L||9|sec|10-14|- OBX|3|NM|APTT^Activated Partial Thromboplastin Time (APTT)^L||28|sec|22-36|N OBX|4|TX|FDP^Fibrinogen Degradation Products^L||< 0.2 (<0.2)||| OBX|5|FT|REPORT^^LN||~\.br\\.br\ Prothrombin Time (PT) 9 *sec (10-14)\.br\ Activated Partial Thromboplastin Time (APTT) 28 sec (22-36)\.br\ Fibrinogen Degradation Products < 0.2 (<0.2)\.br\ Platelets 302 10\S\9/L (150-450)\.br\\.br\\.br\\.br\ Date Collected : 07/01/05\.br\ Time Collected : 08:15\.br\ Episode : 1178481\.br\ ============== ========\.br\\.br\ Prothrombin Ti : 9 *\.br\ Activated Part : 28\.br\ Fibrinogen Deg : 0\.br\ Platelets : 302\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143425|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|FBESR^FBE and ESR^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|NM|Hb^Hb ^L||144|g/L|115-165|N OBX|2|NM|WBC^Total WCC^L||5.5|10^9/L|4-11|N OBX|3|NM|PLT^Platelets^L||302|10^9/L|150-450|N OBX|4|NM|RCC^RCC^L||4.7|10^12/L|3.9-5.6|N OBX|5|NM|PCV^PCV^L||.43|L/L|0.35-0.47|N OBX|6|NM|MCV^MCV^L||93|fL|80-99|N OBX|7|NM|MCH^MCH^L||31|pg|27-32|N OBX|8|NM|MCHC^MCHC^L||333|g/L|310-360|N OBX|9|NM|NE%^Neutrophil^L||62|%||N OBX|10|NM|NE#^Neutrophils^L||3.4||2.0-7.5|N OBX|11|NM|LY%^Lymphocyte ^L||25|%||N OBX|12|NM|LY#^Lymphocytes^L||1.4||1.5-4|- OBX|13|NM|MO%^Monocyte ^L||7|%||N OBX|14|NM|MON#^Monocytes^L||.4||0.2-0.8|N OBX|15|NM|E%^Eosinophil %^L||5|%||N OBX|16|NM|E#^Eosinophils^L||.3||0.04-0.4|N OBX|17|NM|B%^Basophil ^L||1|%||N OBX|18|NM|B#^Basophils^L||.1||0.0-0.1|N OBX|19|NM|ESR^ESR^L||57|mm/hr|1-20|+ OBX|20|FT|REPORT^^LN||~\.br\ Hb 144 g/L (115-165) White Cell Count 5.5 10\S\9/L (4.0-11.0)\.br\ RBC 4.7 10\S\12/L (3.9-5.6) Neutrophils 62 % 3.4 (2.0-7.5)\.br\ PCV 0.43 L/L (0.35-0.47) Lymphocytes 25 % 1.4 * (1.5-4.0)\.br\ MCV 93 fL (80-99) Monocytes 7 % 0.4 (0.2-0.8)\.br\ MCH 31 pg (27-32) Eosinophils 5 % 0.3 (0.0-0.4)\.br\ MCHC 333 g/L (310-360) Basophils 1 % 0.1 (0.0-0.1)\.br\ PLT 302 10\S\9/L (150-450)\.br\ ESR 57 * mm/hr (1-20)\.br\\.br\\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143426|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|LIPIDS^Lipid Profile + HDL^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|NM|Chol^Cholesterol^L||7.6|mmol/L|2-5.5|+ OBX|2|NM|Trig^Triglyceride^L||1.6|mmol/L|0.1-2.5|N OBX|3|NM|HDL^HDL Cholesterol^L||2.0|mmol/L|>1-|N OBX|4|NM|LDL^LDL Cholesterol^L||4.872727272727272728|mmol/L|0-3.5|+ OBX|5|NM|CRR^Coronary Risk Ratio^L||3.8||<5-|N OBX|6|FT|REPORT^^LN||~\.br\ Lipids\.br\ Cholesterol 7.6 *mmol/L (2.0-5.5)\.br\ Triglyceride 1.6 mmol/L (0.1-2.5)\.br\ HDL Chol. 2.0 mmol/L (>1)\.br\ LDL Chol. 4.9 *mmol/L (0.0-3.5)\.br\ Risk Ratio 3.8 (<5)\.br\\.br\ Cholesterol/HDL-C (Risk) ratio of >5.0 may be associated with coronary\.br\ heart disease.\.br\\.br\\.br\\.br\ Date Collected : 07/01/05\.br\ Time Collected : 08:15\.br\ Episode : 1178481\.br\ ============== ========\.br\\.br\ Cholesterol : 7.6 *\.br\ Triglyceride : 1.6\.br\ HDL Chol. : 2.0\.br\ LDL Chol. : 4.9 *\.br\ Risk Ratio : 3.8\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143427|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|MBA^MBA (LFT or EUC)^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|NM|TBili^Bilirubin (Total)^L||18|umol/L|1-24|N OBX|2|NM|ALP^Alkaline Phosphatase^L||336|U/L|30-140|+ OBX|3|NM|GGT^Gamma Glutamyl Transferase^L||415|U/L|1-50|+ OBX|4|NM|ALT^Alanine Transaminase^L||68|U/L|1-50|+ OBX|5|NM|AST^Aspartate Transaminase^L||46|U/L|1-45|+ OBX|6|NM|TP^Total Protein^L||88|g/L|60-81|+ OBX|7|NM|ALB^Albumin^L||48|g/L|35-50|N OBX|8|NM|Glob.^Globulin^L||40|g/L|19-39|+ OBX|9|TX|Comm.^Chem Comment:^L||Common causes of raised GGT and Transaminases could be due to viral disease,\.br\therapeutic drug induced or ethanol induced. Suggest further studies if\.br\clinically indicated.||| OBX|10|NM|Creat.^Creatinine^L||.12|mmol/L|0.05-0.12|N OBX|11|NM|Urea^Urea^L||8.9|mmol/L|3-9|N OBX|12|NM|Na^Na^L||142|mmol/L|136-146|N OBX|13|NM|K^Potassium^L||4.3|mmol/L|3.5-5.2|N OBX|14|NM|Cl^Chloride^L||103|mmol/L|98-109|N OBX|15|NM|HCO3^Bicarbonate^L||28|mmol/L|20-33|N OBX|16|NM|AnionGap^Anion Gap^L||15|mmol/L|10-18|N OBX|17|NM|Chol^Cholesterol^L||7.6|mmol/L|2-5.5|+ OBX|18|NM|Rand.Glu^Random Glucose MBA^L||5|mmol/L|2.8-5.5|N OBX|19|NM|LDH^Lactate Dehydrogenase^L||193|U/L|50-280|N OBX|20|NM|Calcium^Calcium (Total)^L||2.61|mmol/L|2.1-2.55|+ OBX|21|NM|Calcium (Adj)^Calcium (Adjusted)^L||2.45|mmol/L|2.1-2.55|N OBX|22|NM|Phos.^Phosphate^L||1.17|mmol/L|0.75-1.35|N OBX|23|NM|Uric.Acid^Uric Acid^L||.32|mmol/L|0.15-0.45|N OBX|24|FT|REPORT^^LN||~\.br\ General Biochemistry\.br\ Sodium 142 mmol/L (136-146) Phosphate 1.17 mmol/L (0.75-1.35)\.br\ Potassium 4.3 mmol/L (3.5-5.2) Tot.Bili. 18 umol/L (1-24)\.br\ Chloride 103 mmol/L (98-109) Tot.Protein 88 *g/L (60-81)\.br\ Bicarb. 28 mmol/L (20-33) Albumin 48 g/L (35-50)\.br\ Glucose 5.0 mmol/L (2.8-5.5) Globulin 40 *g/L (19-39)\.br\ (fasting) AST 46 *U/L (1-45)\.br\ Urea 8.9 mmol/L (3.0-9.0) ALT 68 *U/L (1-50)\.br\ Creatinine 0.12 mmol/L (0.05-0.12) Alk.Phos 336 *U/L (30-140)\.br\ Uric Acid 0.32 mmol/L (0.15-0.45) GGT 415 *U/L (1-50)\.br\ Tot.Calcium 2.61 *mmol/L (2.10-2.55) LD 193 U/L (50-280)\.br\ Cor.Calcium 2.45 mmol/L (2.10-2.55) Cholesterol 7.6 *mmol/L (2.0-5.5)\.br\\.br\ Common causes of raised GGT and Transaminases could be due to viral disease,\.br\ therapeutic drug induced or ethanol induced. Suggest further studies if\.br\ clinically indicated.\.br\\.br\\.br\\.br\ Date Collected : 07/01/05\.br\ Time Collected : 08:15\.br\ Episode : 1178481\.br\ ============== ========\.br\\.br\ Sodium : 142\.br\ Phosphate : 1.17\.br\ Potassium : 4.3\.br\ Tot.Bili. : 18\.br\ Chloride : 103\.br\ Tot.Protein : 88 *\.br\ Bicarb. : 28\.br\ Albumin : 48\.br\ Glucose : 5.0\.br\ Globulin : 40 *\.br\ AST : 46 *\.br\ Urea : 8.9\.br\ ALT : 68 *\.br\ Creatinine : 0.12\.br\ Alk.Phos : 336 *\.br\ Uric Acid : 0.32\.br\ GGT : 415 *\.br\ Tot.Calcium : 2.61 *\.br\ LD : 193\.br\ Cor.Calcium : 2.45\.br\ Cholesterol : 7.6 *\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143428|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|CRP^C-REACTIVE PROTEIN^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|NM|CRP^C-Reactive Protein^L||9.228880|mg/L|0-5|+ OBX|2|FT|REPORT^^LN||~\.br\ CRP 9 * mg/L (0-5)\.br\\.br\\.br\\.br\ Date Collected : 07/01/05\.br\ Time Collected : 08:15\.br\ Episode : 1178481\.br\ ============== ========\.br\\.br\ CRP : 9 *\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143429|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|U MCS1^Urine MC&S1^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|TX|ERC^Erythrocuytes^L||0||| OBX|2|TX|pH^pH^L||7||| OBX|3|TX|Ptn^Protein^L||+||| OBX|4|TX|Gluc^Glucose^L||Neg||| OBX|5|TX|casts^Urine casts^L||Nil||| OBX|6|TX|com^ Comment -urine^L||In view of the microscropy a repeat sample is suggested if clinically indicated||| OBX|7|NM|Leuc^Leucocytes^L||20|||N OBX|8|TX|Epi^Epithelial cells^L||Occasional||| OBX|9|TX|Blood^Blood dipstick^L||Neg||| OBX|10|TX|Speci^Speci^L||Urine||| OBX|11|TX|Growth^Urine growth^L||No significant growth.||| OBX|12|FT|REPORT^^LN||~\.br\ SPECIMEN: Urine\.br\\.br\ pH: 7 Protein: + Glucose: Neg Blood: Neg\.br\\.br\ Leucocytes: 20 /cmm Erythrocytes: 0 /cmm\.br\ Epithelial cells: Occasional Casts: Nil\.br\\.br\ CULTURE 1. No significant growth.\.br\\.br\ In view of the microscropy a repeat sample is suggested if clinically indicated\.br\\.br\\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143430|L|2.3|||AL|NE PID||SIMIANNA259^^^^^|108358|SIMIANNA259|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1178481||1178481|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1178481|IMM^Immunology ref^L|||200501070815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050106|^DR N GEHLING^^^^ OBX|1|TX|REFTN^Referred Test Name^L||ANA||| OBX|2|TX|^Sent to:^L||Institute of Medical and Veterinary Science.||| OBX|3|TX|^Test line 1^L|| ANTI NUCLEAR ANTIBODY\.br\ Institute of Medical and Veterinary Science (Lab Ref: 05-9003498-ANA)\.br\^~INVISIBLE^^~VISIBLE^\.br\^~INVISIBLE^ Referred by: DR A RAMSEY (Provider: 0302115X)^~VISIBLE^\.br\\.br\^~INVISIBLE^ ANA Screen : Negative^~VISIBLE^\.br\^~INVISIBLE^^~VISIBLE^\.br\^~INVISIBLE^ A negative ANA makes the diagnosis of systemic rheumatic disease,^~VISIBLE^\.br\^~INVISIBLE^ including systemic lupus erythematosis, unlikely.^~VISIBLE^||| OBX|4|FT|REPORT^^LN||~\.br\ Immunology\.br\ Tests performed by Institute of Medical and Veterinary Science.\.br\\.br\ ANTI NUCLEAR ANTIBODY\.br\ Institute of Medical and Veterinary Science (Lab Ref: 05-9003498-ANA)\.br\\.br\ Referred by: DR A RAMSEY (Provider: 0302115X)\.br\\.br\ ANA Screen : Negative\.br\\.br\ A negative ANA makes the diagnosis of systemic rheumatic disease,\.br\ including systemic lupus erythematosis, unlikely.\.br\\.br\\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143431|L|2.3|||AL|NE PID||SIMIANN A280^^^^^|108358|SIMIANN A280|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1201904||1201904|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1201904|LIPIDS^Lipid Profile + HDL^L|||200505030815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050503| OBX|1|NM|Chol^Cholesterol^L||6.6|mmol/L|2-5.5|+ OBX|2|NM|Trig^Triglyceride^L||1.5|mmol/L|0.1-2.5|N OBX|3|NM|HDL^HDL Cholesterol^L||1.8|mmol/L|>1-|N OBX|4|NM|LDL^LDL Cholesterol^L||4.118181818181818182|mmol/L|0-3.5|+ OBX|5|NM|CRR^Coronary Risk Ratio^L||3.666666666666666667||<5-|N OBX|6|FT|REPORT^^LN||~\.br\ Lipids\.br\ Cholesterol 6.6 *mmol/L (2.0-5.5)\.br\ Triglyceride 1.5 mmol/L (0.1-2.5)\.br\ HDL Chol. 1.8 mmol/L (>1)\.br\ LDL Chol. 4.1 *mmol/L (0.0-3.5)\.br\ Risk Ratio 3.7 (<5)\.br\\.br\ Cholesterol/HDL-C (Risk) ratio of >5.0 may be associated with coronary\.br\ heart disease.\.br\\.br\\.br\\.br\ Date Collected : 07/01/05 03/05/05\.br\ Time Collected : 08:15 08:15\.br\ Episode : 1178481 1201904\.br\ ============== ======== ========\.br\\.br\ Cholesterol : 7.6 * 6.6 *\.br\ Triglyceride : 1.6 1.5\.br\ HDL Chol. : 2.0 1.8\.br\ LDL Chol. : 4.9 * 4.1 *\.br\ Risk Ratio : 3.8 3.7\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143432|L|2.3|||AL|NE PID||SIMIANN A280^^^^^|108358|SIMIANN A280|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1201904||1201904|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1201904|MBA^MBA (LFT or EUC)^L|||200505030815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050503| OBX|1|NM|TBili^Bilirubin (Total)^L||21|umol/L|1-24|N OBX|2|NM|ALP^Alkaline Phosphatase^L||413|U/L|30-140|+ OBX|3|NM|GGT^Gamma Glutamyl Transferase^L||305|U/L|1-50|+ OBX|4|NM|ALT^Alanine Transaminase^L||63|U/L|1-50|+ OBX|5|NM|AST^Aspartate Transaminase^L||48|U/L|1-45|+ OBX|6|NM|TP^Total Protein^L||86|g/L|60-81|+ OBX|7|NM|ALB^Albumin^L||46|g/L|35-50|N OBX|8|NM|Glob.^Globulin^L||40|g/L|19-39|+ OBX|9|TX|Comm.^Chem Comment:^L||Abnormal liver enzymes ? partial biliary obstruction ? infiltrative process.||| OBX|10|NM|Creat.^Creatinine^L||.11|mmol/L|0.05-0.12|N OBX|11|NM|Urea^Urea^L||8.8|mmol/L|3-9|N OBX|12|NM|Na^Na^L||141|mmol/L|136-146|N OBX|13|NM|K^Potassium^L||4|mmol/L|3.5-5.2|N OBX|14|NM|Cl^Chloride^L||101|mmol/L|98-109|N OBX|15|NM|HCO3^Bicarbonate^L||31|mmol/L|20-33|N OBX|16|NM|AnionGap^Anion Gap^L||13|mmol/L|10-18|N OBX|17|NM|Chol^Cholesterol^L||6.6|mmol/L|2-5.5|+ OBX|18|NM|Rand.Glu^Random Glucose MBA^L||4.6|mmol/L|2.8-5.5|N OBX|19|NM|LDH^Lactate Dehydrogenase^L||181|U/L|50-280|N OBX|20|NM|Calcium^Calcium (Total)^L||2.56|mmol/L|2.1-2.55|+ OBX|21|NM|Calcium (Adj)^Calcium (Adjusted)^L||2.44|mmol/L|2.1-2.55|N OBX|22|NM|Phos.^Phosphate^L||1.1|mmol/L|0.75-1.35|N OBX|23|NM|Uric.Acid^Uric Acid^L||.31|mmol/L|0.15-0.45|N OBX|24|FT|REPORT^^LN||~\.br\ General Biochemistry\.br\ Sodium 141 mmol/L (136-146) Phosphate 1.10 mmol/L (0.75-1.35)\.br\ Potassium 4.0 mmol/L (3.5-5.2) Tot.Bili. 21 umol/L (1-24)\.br\ Chloride 101 mmol/L (98-109) Tot.Protein 86 *g/L (60-81)\.br\ Bicarb. 31 mmol/L (20-33) Albumin 46 g/L (35-50)\.br\ Glucose 4.6 mmol/L (2.8-5.5) Globulin 40 *g/L (19-39)\.br\ (fasting) AST 48 *U/L (1-45)\.br\ Urea 8.8 mmol/L (3.0-9.0) ALT 63 *U/L (1-50)\.br\ Creatinine 0.11 mmol/L (0.05-0.12) Alk.Phos 413 *U/L (30-140)\.br\ Uric Acid 0.31 mmol/L (0.15-0.45) GGT 305 *U/L (1-50)\.br\ Tot.Calcium 2.56 *mmol/L (2.10-2.55) LD 181 U/L (50-280)\.br\ Cor.Calcium 2.44 mmol/L (2.10-2.55) Cholesterol 6.6 *mmol/L (2.0-5.5)\.br\\.br\ Abnormal liver enzymes ? partial biliary obstruction ? infiltrative process.\.br\\.br\\.br\\.br\ Date Collected : 07/01/05 03/05/05\.br\ Time Collected : 08:15 08:15\.br\ Episode : 1178481 1201904\.br\ ============== ======== ========\.br\\.br\ Sodium : 142 141\.br\ Phosphate : 1.17 1.10\.br\ Potassium : 4.3 4.0\.br\ Tot.Bili. : 18 21\.br\ Chloride : 103 101\.br\ Tot.Protein : 88 * 86 *\.br\ Bicarb. : 28 31\.br\ Albumin : 48 46\.br\ Glucose : 5.0 4.6\.br\ Globulin : 40 * 40 *\.br\ AST : 46 * 48 *\.br\ Urea : 8.9 8.8\.br\ ALT : 68 * 63 *\.br\ Creatinine : 0.12 0.11\.br\ Alk.Phos : 336 * 413 *\.br\ Uric Acid : 0.32 0.31\.br\ GGT : 415 * 305 *\.br\ Tot.Calcium : 2.61 * 2.56 *\.br\ LD : 193 181\.br\ Cor.Calcium : 2.45 2.44\.br\ Cholesterol : 7.6 * 6.6 *\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143433|L|2.3|||AL|NE PID||SIMIANN A280^^^^^|108358|SIMIANN A280|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||302115X^Ramsey^A L^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1201904||1201904|IP||||200509011615|||302115X^Ramsey^A L^^^Dr OBR|1||1201904|Hep^Hepatitis Serology ref^L|||200505030815|||||N||||302115X^Ramsey^A L^^^Dr||||||200509011615|||F||^^^20050503| OBX|1|TX|REFTN^Referred Test Name^L||Hepatits B C||| OBX|2|TX|^Sent to:^L||Institute of Medical and Veterinary Science.||| OBX|3|TX|^Test line 1^L|| HEPATITIS SEROLOGY\.br\ Institute of Medical and Veterinary Science (Lab Ref: 05-9050412-HEP)\.br\^~INVISIBLE^^~VISIBLE^\.br\^~INVISIBLE^ Referred by: DR A RAMSAY (Provider: 0152421T)^~VISIBLE^\.br\\.br\^~INVISIBLE^ Hepatitis B surface antigen: NOT DETECTED^~VISIBLE^\.br\^~INVISIBLE^^~VISIBLE^\.br\^~INVISIBLE^ Hepatitis C antibody: NOT DETECTED^~VISIBLE^||| OBX|4|FT|REPORT^^LN||~\.br\ Hepatitis Serology\.br\ Tests performed by Institute of Medical and Veterinary Science.\.br\\.br\ HEPATITIS SEROLOGY\.br\ Institute of Medical and Veterinary Science (Lab Ref: 05-9050412-HEP)\.br\\.br\ Referred by: DR A RAMSAY (Provider: 0152421T)\.br\\.br\ Hepatitis B surface antigen: NOT DETECTED\.br\\.br\ Hepatitis C antibody: NOT DETECTED\.br\\.br\\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143434|L|2.3|||AL|NE PID||SIMIANNA840^^^^^|108358|SIMIANNA840|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||236015ML^Boyer^S^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1257249||1257249|IP||||200509011615|||236015ML^Boyer^S^^^Dr OBR|1||1257249|FBESR^FBE and ESR^L|||200508260000|||||N||||236015ML^Boyer^S^^^Dr||||||200509011615|||F||^^^20050826| OBX|1|NM|Hb^Hb ^L||122|g/L|115-165|N OBX|2|NM|WBC^Total WCC^L||7.3|10^9/L|4-11|N OBX|3|NM|PLT^Platelets^L||322|10^9/L|150-450|N OBX|4|NM|RCC^RCC^L||3.9|10^12/L|3.9-5.6|N OBX|5|NM|PCV^PCV^L||.36|L/L|0.35-0.47|N OBX|6|NM|MCV^MCV^L||92|fL|80-99|N OBX|7|NM|MCH^MCH^L||31|pg|27-32|N OBX|8|NM|MCHC^MCHC^L||337|g/L|310-360|N OBX|9|NM|NE%^Neutrophil^L||58|%||N OBX|10|NM|NE#^Neutrophils^L||4.2||2.0-7.5|N OBX|11|NM|LY%^Lymphocyte ^L||24|%||N OBX|12|NM|LY#^Lymphocytes^L||1.8||1.5-4|N OBX|13|NM|MO%^Monocyte ^L||14|%||N OBX|14|NM|MON#^Monocytes^L||1||0.2-0.8|+ OBX|15|NM|E%^Eosinophil %^L||5|%||N OBX|16|NM|E#^Eosinophils^L||.4||0.04-0.4|N OBX|17|NM|B%^Basophil ^L||0|%||N OBX|18|NM|B#^Basophils^L||0||0.0-0.1|N OBX|19|NM|ESR^ESR^L||90|mm/hr|1-20|+ OBX|20|TX|^Haem. comment^L||Now markedly elevated ESR - ?infection or inflammation.\.br\\.br\ Richard Abbott.||| OBX|21|FT|REPORT^^LN||~\.br\ Hb 122 g/L (115-165) White Cell Count 7.3 10\S\9/L (4.0-11.0)\.br\ RBC 3.9 10\S\12/L (3.9-5.6) Neutrophils 58 % 4.2 (2.0-7.5)\.br\ PCV 0.36 L/L (0.35-0.47) Lymphocytes 24 % 1.8 (1.5-4.0)\.br\ MCV 92 fL (80-99) Monocytes 14 % 1.0 * (0.2-0.8)\.br\ MCH 31 pg (27-32) Eosinophils 5 % 0.4 (0.0-0.4)\.br\ MCHC 337 g/L (310-360) Basophils 0 % 0.0 (0.0-0.1)\.br\ PLT 322 10\S\9/L (150-450)\.br\ ESR 90 * mm/hr (1-20)\.br\\.br\ COMMENT:\.br\ Now markedly elevated ESR - ?infection or inflammation.\.br\\.br\ Richard Abbott.\.br\\.br\\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143435|L|2.3|||AL|NE PID||SIMIANNA840^^^^^|108358|SIMIANNA840|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||236015ML^Boyer^S^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1257249||1257249|IP||||200509011615|||236015ML^Boyer^S^^^Dr OBR|1||1257249|MBA^MBA (LFT or EUC)^L|||200508260000|||||N||||236015ML^Boyer^S^^^Dr||||||200509011615|||F||^^^20050826| OBX|1|NM|TBili^Bilirubin (Total)^L||10|umol/L|1-24|N OBX|2|NM|ALP^Alkaline Phosphatase^L||429|U/L|30-140|+ OBX|3|NM|GGT^Gamma Glutamyl Transferase^L||234|U/L|1-50|+ OBX|4|NM|ALT^Alanine Transaminase^L||54|U/L|1-50|+ OBX|5|NM|AST^Aspartate Transaminase^L||40|U/L|1-45|N OBX|6|NM|TP^Total Protein^L||79|g/L|60-81|N OBX|7|NM|ALB^Albumin^L||42|g/L|35-50|N OBX|8|NM|Glob.^Globulin^L||37|g/L|19-39|N OBX|9|TX|Comm.^Chem Comment:^L||The liver enzyme pattern is suggestive of a localised cholestatic process. Eg.\.br\drug or alcohol induced cholestasis, fatty infiltration of the liver, etc.||| OBX|10|NM|Creat.^Creatinine^L||.09|mmol/L|0.05-0.12|N OBX|11|NM|Urea^Urea^L||9.2|mmol/L|3-9|+ OBX|12|NM|Na^Na^L||139|mmol/L|136-146|N OBX|13|NM|K^Potassium^L||4.4|mmol/L|3.5-5.2|N OBX|14|NM|Cl^Chloride^L||102|mmol/L|98-109|N OBX|15|NM|HCO3^Bicarbonate^L||27|mmol/L|20-33|N OBX|16|NM|AnionGap^Anion Gap^L||14|mmol/L|10-18|N OBX|17|NM|Chol^Cholesterol^L||3.2|mmol/L|2-5.5|N OBX|18|NM|Rand.Glu^Random Glucose MBA^L||5|mmol/L|2.8-5.5|N OBX|19|NM|LDH^Lactate Dehydrogenase^L||171|U/L|50-280|N OBX|20|NM|Calcium^Calcium (Total)^L||2.46|mmol/L|2.1-2.55|N OBX|21|NM|Calcium (Adj)^Calcium (Adjusted)^L||2.42|mmol/L|2.1-2.55|N OBX|22|NM|Phos.^Phosphate^L||1.49|mmol/L|0.75-1.35|+ OBX|23|NM|Uric.Acid^Uric Acid^L||.23|mmol/L|0.15-0.45|N OBX|24|FT|REPORT^^LN||~\.br\ General Biochemistry\.br\ Sodium 139 mmol/L (136-146) Phosphate 1.49 *mmol/L (0.75-1.35)\.br\ Potassium 4.4 mmol/L (3.5-5.2) Tot.Bili. 10 umol/L (1-24)\.br\ Chloride 102 mmol/L (98-109) Tot.Protein 79 g/L (60-81)\.br\ Bicarb. 27 mmol/L (20-33) Albumin 42 g/L (35-50)\.br\ Glucose 5.0 mmol/L (2.8-5.5) Globulin 37 g/L (19-39)\.br\ (fasting) AST 40 U/L (1-45)\.br\ Urea 9.2 *mmol/L (3.0-9.0) ALT 54 *U/L (1-50)\.br\ Creatinine 0.09 mmol/L (0.05-0.12) Alk.Phos 429 *U/L (30-140)\.br\ Uric Acid 0.23 mmol/L (0.15-0.45) GGT 234 *U/L (1-50)\.br\ Tot.Calcium 2.46 mmol/L (2.10-2.55) LD 171 U/L (50-280)\.br\ Cor.Calcium 2.42 mmol/L (2.10-2.55) Cholesterol 3.2 mmol/L (2.0-5.5)\.br\\.br\ The liver enzyme pattern is suggestive of a localised cholestatic process. Eg.\.br\ drug or alcohol induced cholestasis, fatty infiltration of the liver, etc.\.br\\.br\\.br\\.br\ Date Collected : 07/01/05 03/05/05 26/08/05\.br\ Time Collected : 08:15 08:15 N/S\.br\ Episode : 1178481 1201904 1257249\.br\ ============== ======== ======== ========\.br\\.br\ Sodium : 142 141 139\.br\ Phosphate : 1.17 1.10 1.49 *\.br\ Potassium : 4.3 4.0 4.4\.br\ Tot.Bili. : 18 21 10\.br\ Chloride : 103 101 102\.br\ Tot.Protein : 88 * 86 * 79\.br\ Bicarb. : 28 31 27\.br\ Albumin : 48 46 42\.br\ Glucose : 5.0 4.6 5.0\.br\ Globulin : 40 * 40 * 37\.br\ AST : 46 * 48 * 40\.br\ Urea : 8.9 8.8 9.2 *\.br\ ALT : 68 * 63 * 54 *\.br\ Creatinine : 0.12 0.11 0.09\.br\ Alk.Phos : 336 * 413 * 429 *\.br\ Uric Acid : 0.32 0.31 0.23\.br\ GGT : 415 * 305 * 234 *\.br\ Tot.Calcium : 2.61 * 2.56 * 2.46\.br\ LD : 193 181 171\.br\ Cor.Calcium : 2.45 2.44 2.42\.br\ Cholesterol : 7.6 * 6.6 * 3.2\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143436|L|2.3|||AL|NE PID||SIMIANNA840^^^^^|108358|SIMIANNA840|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||236015ML^Boyer^S^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1257249||1257249|IP||||200509011615|||236015ML^Boyer^S^^^Dr OBR|1||1257249|RF^RHEUMATOID FACTOR^L|||200508260000|||||N||||236015ML^Boyer^S^^^Dr||||||200509011615|||F||^^^20050826| OBX|1|NM|RHF^Rheumatoid Factor^L||11|IU/mL|<14-|N OBX|2|FT|REPORT^^LN||~\.br\ SPECIAL CHEMISTRY\.br\ Rheum. Factor 11 IU/mL (<14)\.br\\.br\\.br\\.br\ Date Collected : 26/08/05\.br\ Time Collected : N/S\.br\ Episode : 1257249\.br\ ============== ========\.br\\.br\ Rheum. Factor : 11\.br\ MSH|^~\&|LABTRAK|Abbott Pathology|PATH_RESULTS||200509011615||ORU^R01|143437|L|2.3|||AL|NE PID||SIMIANNA840^^^^^|108358|SIMIANNA840|Simic^Ann^^^||19481008|F|||BOX 1198^^MT BARKER^^5251||8398 4242||||||4093047785|||||||| PV1||*||||||236015ML^Boyer^S^^^Dr|0255993K^Clapp^Randall^^^DR ORC|OK|1257249||1257249|IP||||200509011615|||236015ML^Boyer^S^^^Dr OBR|1||1257249|VIRAL^Serology ref^L|||200508260000|||||N||||236015ML^Boyer^S^^^Dr||||||200509011615|||F||^^^20050826| OBX|1|TX|REFTN^Referred Test Name^L||ANA||| OBX|2|TX|^Sent to:^L||Institute of Medical and Veterinary Science.||| OBX|3|TX|^Test line 1^L|| ANTI NUCLEAR ANTIBODY\.br\ Institute of Medical and Veterinary Science (Lab Ref: 05-9098760-ANA)\.br\^~INVISIBLE^^~VISIBLE^\.br\^~INVISIBLE^ Referred by: DR SUE BOYER (Provider: 236015ML)^~VISIBLE^\.br\\.br\^~INVISIBLE^ ANA Screen : Negative^~VISIBLE^\.br\^~INVISIBLE^^~VISIBLE^\.br\^~INVISIBLE^ A negative ANA makes the diagnosis of systemic rheumatic disease,^~VISIBLE^\.br\^~INVISIBLE^ including systemic lupus erythematosis, unlikely.^~VISIBLE^||| OBX|4|FT|REPORT^^LN||~\.br\ Viral Serology\.br\ Tests performed by Institute of Medical and Veterinary Science.\.br\\.br\ ANTI NUCLEAR ANTIBODY\.br\ Institute of Medical and Veterinary Science (Lab Ref: 05-9098760-ANA)\.br\\.br\ Referred by: DR SUE BOYER (Provider: 236015ML)\.br\\.br\ ANA Screen : Negative\.br\\.br\ A negative ANA makes the diagnosis of systemic rheumatic disease,\.br\ including systemic lupus erythematosis, unlikely.\.br\\.br\\.br\ BTS|14 FTS|1|